Advertisement
 
  Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
    « Previous Issue | Next Issue »
  Cover Image

Volume 27, Issue 12; December 1, 2007

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

 

EditorialsBack

Scavenger Receptor A and CD36 Are Implicated in Mediating Platelet Activation Induced by Oxidized Low- Density Lipoproteins

Sophie Collot-Teixeira, Ferrucio Delorenzo, and John L. McGregor
Arterioscler Thromb Vasc Biol. 2007;27:2491-2492, doi:10.1161/ATVBAHA.107.154864
Extract | Full Text | PDF  

The Influence of the Regulatory T Lymphocytes on Atherosclerosis

Israel Gotsman, Rajat Gupta, and Andrew H. Lichtman
Arterioscler Thromb Vasc Biol. 2007;27:2493-2495; published online before print September 27 2007, doi:10.1161/ATVBAHA.107.153064
Extract | Full Text | PDF  

Epoxyeicosatrienoic Acids, TRP Channels, and Intracellular Ca2+ in the Vasculature: An Endothelium-Derived Endothelium-Hyperpolarizing Factor?

Brandon T. Larsen, David X. Zhang, and David D. Gutterman
Arterioscler Thromb Vasc Biol. 2007;27:2496-2498; published online before print October 25 2007, doi:10.1161/ATVBAHA.107.155341
Extract | Full Text | PDF  

 

Brief ReviewsBack

Godfrey S. Getz and Catherine A. Reardon
Arterioscler Thromb Vasc Biol. 2007;27:2499-2506; published online before print October 22 2007, doi:10.1161/ATVBAHA.107.155853
Abstract | Full Text | PDF
Many risk factors for cardiovascular diseases are profoundly affected by diet. Although most of the information about nutritional risk factors and cardiovascular disease derives from studies in the developed world, the situation is rapidly evolving toward epidemic proportions in the developing world, leading to impending economic and health service burdens.  

David Gailani and Thomas Renné
Arterioscler Thromb Vasc Biol. 2007;27:2507-2513; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.155952
Abstract | Full Text | PDF
Deficiencies of the plasma proteases factor XII and factor XI are not associated with abnormal hemostasis in mice but prevent thrombus formation in arterial injury models. If factor XII or factor XI make similar contributions to thrombosis in humans, they could be therapeutic targets to treat or prevent thromboembolic disease.  

Abigail Woodfin, Mathieu-Benoit Voisin, and Sussan Nourshargh
Arterioscler Thromb Vasc Biol. 2007;27:2514-2523; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.151456
Abstract | Full Text | PDF
This review discusses multiple roles of PECAM in inflammation and vascular biology, focusing on the emerging complexities associated with its role in leukocyte transendothelial migration. The review also discusses potential interaction of PECAM-1 with other endothelial cell junctional molecules and the role of PECAM-1 in various vascular and inflammatory disorders.  

Jorge D. Erusalimsky and Salvador Moncada
Arterioscler Thromb Vasc Biol. 2007;27:2524-2531; published online before print September 20 2007, doi:10.1161/ATVBAHA.107.151167
Abstract | Full Text | PDF
This review summarizes the evidence showing that binding of NO to cytochrome C oxidase elicits signaling events by which mitochondria modulate cellular defense mechanisms and adaptive responses. We also discuss instances in which the effects of NO on the electron transport chain might lead to mitochondrial dysfunction and pathology.  

Masaki Mogi, Masaru Iwai, and Masatsugu Horiuchi
Arterioscler Thromb Vasc Biol. 2007;27:2532-2539; published online before print August 23 2007, doi:10.1161/ATVBAHA.107.144154
Abstract | Full Text | PDF
Recently, new evidence has accumulated showing the existence of several novel receptor interacting proteins and various angiotensin II receptor activation mechanisms such as dimerization and mechanical stretch-induced activation beyond the classical actions. In this review, these emerging concepts and a new insight into future drug discovery are discussed.  

 

Vascular BiologyBack

Ela Karshovska, Alma Zernecke, Gueler Sevilmis, Andrea Millet, Mihail Hristov, Clemens D. Cohen, Holger Schmid, Florian Krotz, Hae-Young Sohn, Volker Klauss, Christian Weber, and Andreas Schober
Arterioscler Thromb Vasc Biol. 2007;27:2540-2547; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.151050
Abstract | Full Text | PDF | Data Supplement
We studied the role of hypoxia-inducible factor (HIF)-1{alpha} in neointima formation after vascular injury in apolipoprotein E-deficient mice. Inhibition of injury-induced HIF-1{alpha} upregulation reduced the neointimal area and stromal cell-derived factor (SDF)-1{alpha} expression. This suggests a direct contribution of HIF-1{alpha} to SDF-1{alpha}-mediated neointima formation after vascular injury.  

Masaomi Nangaku, Yuko Izuhara, Shunya Takizawa, Toshiharu Yamashita, Yoshiaki Fujii-Kuriyama, Osamu Ohneda, Masayuki Yamamoto, Charles van Ypersele de Strihou, Noriaki Hirayama, and Toshio Miyata
Arterioscler Thromb Vasc Biol. 2007;27:2548-2554; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.148551
Abstract | Full Text | PDF | Data Supplement
We discovered 2 compounds (TM6008 and TM6089) that inhibited PHD and stabilized HIF activity. Local administration of TM6008 and TM6089 enhanced angiogenesis, and their oral administration stimulated HIF activity in transgenic rats expressing a hypoxia-responsive reporter vector. Oral administration of TM6008 protected neurons in a model of ischemic cerebrovascular disease.  

Kanako Izumi-Nagai, Norihiro Nagai, Kazuhiro Ohgami, Shingo Satofuka, Yoko Ozawa, Kazuo Tsubota, Kazuo Umezawa, Shigeaki Ohno, Yuichi Oike, and Susumu Ishida
Arterioscler Thromb Vasc Biol. 2007;27:2555-2562; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.151431
Abstract | Full Text | PDF
We investigate the effect of lutein on experimental choroidal neovascularization (CNV) and revealed that lutein inhibits CNV development together with inflammatory processes including NF-{kappa}B activation and subsequent upregulation of inflammatory molecules, providing molecular evidence of potential validity of lutein supplementation as a therapeutic strategy to suppress CNV.  

Kensuke Egashira, Kaku Nakano, Kisho Ohtani, Kouta Funakoshi, Gang Zhao, Yoshiko Ihara, Jun-ichiro Koga, Satoshi Kimura, Ryuji Tominaga, and Kenji Sunagawa
Arterioscler Thromb Vasc Biol. 2007;27:2563-2568; published online before print September 20 2007, doi:10.1161/ATVBAHA.107.154609
Abstract | Full Text | PDF | Data Supplement
We created stents coated with 7ND gene, which attenuated stent-associated monocyte infiltration and neointima formation in rabbits, and showed long-term inhibitory effects on neointima formation in monkeys. No adverse effects of 7ND-eluting stent were noted. Therefore, 7ND gene-eluting stent might be useful for treatment of restenosis in humans.  

Eiichiro Yamamoto, Keiichiro Kataoka, Haruo Shintaku, Takuro Yamashita, Yoshiko Tokutomi, Yi-Fei Dong, Shinji Matsuba, Hidenori Ichijo, Hisao Ogawa, and Shokei Kim-Mitsuyama
Arterioscler Thromb Vasc Biol. 2007;27:2569-2575; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.153692
Abstract | Full Text | PDF | Data Supplement
We examined the mechanism and significance of angiotensin II (AII)-induced vascular endothelial injury. AII-induced vascular endothelial apoptosis and eNOS uncoupling were mediated by apoptosis signal-regulating kinase 1 and contributed to the exacerbation of vascular injury of salt-sensitive hypertensive rats with diastolic heart failure.  

Laura I. Schrader, Dale A. Kinzenbaw, Andrew W. Johnson, Frank M. Faraci, and Sean P. Didion
Arterioscler Thromb Vasc Biol. 2007;27:2576-2581; published online before print October 25 2007, doi:10.1161/ATVBAHA.107.153080
Abstract | Full Text | PDF | Data Supplement
The role of IL-6 in endothelial dysfunction and oxidative stress produced by angiotensin II was investigated. IL-6 deficiency was associated with reductions in angiotensin II-induced endothelial dysfunction, vascular hypertrophy, and superoxide. Thus, IL-6 produced locally, within the vessel wall, contributes substantially to the vascular dysfunction produced by angiotensin II.  

Jeff S. Isenberg, Fuminori Hyodo, Loretta K. Pappan, Mones Abu-Asab, Maria Tsokos, Murali C. Krishna, William A. Frazier, and David D. Roberts
Arterioscler Thromb Vasc Biol. 2007;27:2582-2588; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.155390
Abstract | Full Text | PDF | Data Supplement
Decreased blood flow and wound healing are common in the elderly. Nitric oxide can increase both tissue blood flow and healing, but thrombospondin-1 limits responses to nitric oxide in aged mice. Blocking the thrombospondin-1 receptor CD47 restores blood flow and increases tissue healing.  

Ziyad Al-Aly, Jian-Su Shao, Chung-Fang Lai, Emily Huang, Jun Cai, Abraham Behrmann, Su-Li Cheng, and Dwight A. Towler
Arterioscler Thromb Vasc Biol. 2007;27:2589-2596; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.153668
Abstract | Full Text | PDF | Data Supplement
Type II diabetes (T2DM) promotes medial artery calcification, a significant risk factor for lower extremity amputation. Using a murine disease model--the Ldlr-/- mouse fed high fat diabetogenic diets--we identified that arterial TNF-alpha signaling activates osteogenic Msx2-Wnt gene expression programs that direct medial calcification during disease initiation.  

Minzhou Huang, James B. DuHadaway, George C. Prendergast, and Lisa D. Laury-Kleintop
Arterioscler Thromb Vasc Biol. 2007;27:2597-2605; published online before print October 19 2007, doi:10.1161/ATVBAHA.107.154211
Abstract | Full Text | PDF | Data Supplement
Herein, we show that in vascular smooth muscle cells RhoB plays a critical role in trafficking and signaling by the platelet-derived growth factor receptor-β. Cells derived from RhoB knockout mice failed to proliferate in response to PDGF and downstream signaling was compromised as reflected by reduced Akt and ERK1/2 phosphorylation.  

Yoyo T.Y. Li, Karen E. Swales, Gareth J. Thomas, Timothy D. Warner, and David Bishop-Bailey
Arterioscler Thromb Vasc Biol. 2007;27:2606-2611, doi:10.1161/ATVBAHA.107.152694
Abstract | Full Text | PDF | Data Supplement
FXR is expressed in vascular smooth muscle cells. Here we show that in addition to antiproliferative properties, activation of FXR inhibits inflammation and migration of vascular smooth muscle cells. FXR may therefore be a novel direct target for vascular disease.  

Ingrid Fleming, Alexandra Rueben, Rüdiger Popp, Beate Fisslthaler, Susanne Schrodt, Anna Sander, Judith Haendeler, John R. Falck, Christophe Morisseau, Bruce D. Hammock, and Rudi Busse
Arterioscler Thromb Vasc Biol. 2007;27:2612-2618; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.152074
Abstract | Full Text | PDF | Data Supplement
Bradykinin-induced Ca2+ influx and Ca2+-dependent K+ channel activation in endothelial cells is potentiated by cytochrome P450 (CYP) expression and soluble epoxide hydrolase (sEH) inhibition. An epoxyeicosatrienoic acid-induced translocation of a TrpC6-V5 fusion protein to the endothelial cell membrane via a cAMP-dependent mechanism can account for these findings.  

Clarence M. Findley, Melissa J. Cudmore, Asif Ahmed, and Christopher D. Kontos
Arterioscler Thromb Vasc Biol. 2007;27:2619-2626; published online before print September 27 2007, doi:10.1161/ATVBAHA.107.150482
Abstract | Full Text | PDF | Data Supplement
Tie2 plays an important role in vascular remodeling. We demonstrate that soluble Tie2 shedding is induced by vascular endothelial growth factor (VEGF) in a phosphoinositide 3-kinase/Akt-dependent manner. These findings suggest a novel mechanism by which VEGF may inhibit Tie2-mediated vascular stabilization to promote angiogenesis and vascular remodeling.  

Giulio Ceolotto, Alessandra Gallo, Italia Papparella, Lorenzo Franco, Ellen Murphy, Elisabetta Iori, Elisa Pagnin, Gian Paolo Fadini, Mattia Albiero, Andrea Semplicini, and Angelo Avogaro
Arterioscler Thromb Vasc Biol. 2007;27:2627-2633; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.155762
Abstract | Full Text | PDF | Data Supplement
The present study was designed to characterize the molecular mechanisms underlying the effects of rosiglitazone on hyperglycemia-induced ROS production in HUVECs. We demonstrate that rosiglitazone reduces glucose-induced oxidative stress through inhibition of NAD(P)H oxidase. This effect is not mediated by PPAR{gamma} but is dependent on AMPK activation and downstream PKC inhibition.  

Lee A. O’Brien, Mark A. Richardson, Sean F. Mehrbod, David T. Berg, Bruce Gerlitz, Akanksha Gupta, and Brian W. Grinnell
Arterioscler Thromb Vasc Biol. 2007;27:2634-2641; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.153734
Abstract | Full Text | PDF | Data Supplement
We report that APC can suppress the proapoptotic mediator TRAIL by activating the ERK pathway to upregulate EGR-1, a negative regulator of TRAIL expression. The effect of APC was PAR-1- and S1P1-dependent, but independent of the endothelial protein C receptor, suggesting a mechanism to suppress injury in cells not expressing this receptor.  

Ioanna Kosmidou, Jeffrey P. Moore, Martina Weber, and Charles D. Searles
Arterioscler Thromb Vasc Biol. 2007;27:2642-2649; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.154492
Abstract | Full Text | PDF | Data Supplement
We examined the effect of statins on eNOS mRNA polyadenylation, a process known to increase mRNA stability and translation. Statins increased polyadenylation in a time- and dose-dependent manner through a mechanism that appears to involve Rho-induced changes in the actin cytoskeleton.  

Naomi M. Hamburg, Craig J. McMackin, Alex L. Huang, Sherene M. Shenouda, Michael E. Widlansky, Eberhard Schulz, Noyan Gokce, Neil B. Ruderman, John F. Keaney, Jr, and Joseph A. Vita
Arterioscler Thromb Vasc Biol. 2007;27:2650-2656; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.153288
Abstract | Full Text | PDF
Physical inactivity is associated with cardiovascular disease. We examined the effect of 5 days of bed rest on insulin resistance and vascular function in healthy subjects. Bed rest induced vascular dysfunction, insulin resistance, dyslipidemia, and increased blood pressure. Our findings provide insight into the pathogenesis of vascular disease in sedentary individuals.  

Robert Gros, Stan Van Uum, Adam Hutchinson-Jaffe, Qingming Ding, J. Geoffrey Pickering, Robert A. Hegele, and Ross D. Feldman
Arterioscler Thromb Vasc Biol. 2007;27:2657-2663; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.145557
Abstract | Full Text | PDF
We examined the phenotypic characteristics of an adenylyl cyclase 6 (ADCY6 S674) variant in human subjects and isolated human mononuclear leukocytes and rat smooth muscle cells. Our data demonstrate that expression of this ADCY6 S674 variant is associated with enhanced adenylyl cyclase activity and enhanced cAMP-mediated regulation of contractile responses.  

Mark E. Kleinman, Matthew R. Greives, Samara S. Churgin, Keith M. Blechman, Eric I. Chang, Daniel J. Ceradini, Oren M. Tepper, and Geoffrey C. Gurtner
Arterioscler Thromb Vasc Biol. 2007;27:2664-2670; published online before print September 13 2007, doi:10.1161/ATVBAHA.107.150284
Abstract | Full Text | PDF | Data Supplement
The pathophysiology of infantile hemangioma is unknown, yet there is evidence to suggest that stem/progenitor cells may contribute to their rapid proliferation. We investigated the mediators of progenitor cell mobilization and recruitment in children with hemangioma and demonstrate that growth may be linked to hypoxia and activation of vasculogenic pathways.  

 

Atherosclerosis and LipoproteinsBack

Susanna S. Wang, Weibin Shi, Xuping Wang, Leandra Velky, Sarah Greenlee, Min T. Wang, Thomas A. Drake, and Aldons J. Lusis
Arterioscler Thromb Vasc Biol. 2007;27:2671-2676; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.148106
Abstract | Full Text | PDF | Data Supplement
An F2 intercross between C57BL/6J and C3H/HeJ on the ApoE-/- background, fed on a chow diet and euthanized at 12 weeks exhibited one significant QTL on chromosome 9, Ath29 and a suggestive QTL on chromosome 4, Ath8. Congenics for Ath29 confirmed the contribution of the locus to lesion development.  

G.H.M. van Puijvelde, T. van Es, E.J.A. van Wanrooij, K.L.L. Habets, P. de Vos, R. van der Zee, W. van Eden, Th. J.C. van Berkel, and J. Kuiper
Arterioscler Thromb Vasc Biol. 2007;27:2677-2683; published online before print September 27 2007, doi:10.1161/ATVBAHA.107.151274
Abstract | Full Text | PDF | Data Supplement
HSP60-specific T cells contributing to the development of atherosclerosis can be counteracted by Tregs, which can be activated by oral tolerance induction to HSP60 and may produce IL-10 and TGF-β. This results in a beneficial effect on atherosclerosis and may provide a new therapeutic approach for the treatment of atherosclerosis.  

Sergiy Sukhanov, Yusuke Higashi, Shaw-Yung Shai, Charlotte Vaughn, Jessica Mohler, Yangxin Li, Yao-Hua Song, Jane Titterington, and Patrick Delafontaine
Arterioscler Thromb Vasc Biol. 2007;27:2684-2690; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.156257
Abstract | Full Text | PDF | Data Supplement
Although insulin-like growth factor-1 (IGF-1) has been described to have pleiotropic effects in the vasculature, its role in the development and progression of atherosclerosis is obscure. Here we report that in ApoE-deficient mice fed a high-fat diet continuous infusion of IGF-1 suppressed progression of atherosclerosis potentially via antiinflammatory, antioxidant, and prorepair effects.  

Soraya Taleb, Olivier Herbin, Hafid Ait-Oufella, Wim Verreth, Pierre Gourdy, Véronique Barateau, Régine Merval, Bruno Esposito, Karine Clément, Paul Holvoet, Alain Tedgui, and Ziad Mallat
Arterioscler Thromb Vasc Biol. 2007;27:2691-2698; published online before print August 9 2007, doi:10.1161/ATVBAHA.107.149567
Abstract | Full Text | PDF
Leptin, a hormone that increases with obesity, was suggested to either accelerate or protect from atherosclerosis. Here, we identify a critical role for leptin/leptin receptor pathway in the modulation of the regulatory immune response in atherosclerosis, and suggest that alteration in regulatory immunity may predispose obese individuals to atherosclerosis.  

Jochen G. Schneider, Yimin Zhu, Trey Coleman, and Clay F. Semenkovich
Arterioscler Thromb Vasc Biol. 2007;27:2699-2706; published online before print October 19 2007, doi:10.1161/ATVBAHA.107.153650
Abstract | Full Text | PDF | Data Supplement
The signals linking hyperlipidemia and the chronic inflammation characteristic of atherosclerosis are unknown. Here we demonstrate that the β3 integrin on macrophages suppresses diet-induced inflammation in hyperlipidemic mice by decreasing expression of TNF{alpha}. Promoting anti-inflammatory signaling mediated by the β3 integrin could represent a novel treatment strategy for atherosclerosis.  

Christopher J. Lelliott, Anna Ljungberg, Andrea Ahnmark, Lena William-Olsson, Kim Ekroos, Anders Elmgren, Gunnel Arnerup, Carol C. Shoulders, Jan Oscarsson, and Daniel Lindén
Arterioscler Thromb Vasc Biol. 2007;27:2707-2713; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.155739
Abstract | Full Text | PDF | Data Supplement
The effects of increased hepatic expression of PGC-1{alpha} or PGC-1β on PPAR{alpha} activation, gene expression, and lipid metabolism were investigated. PGC-1β overexpression induced a combined hyperlipidemia and blunted the effects of PPAR{alpha} activation on gene expression. Thus, inhibition of hepatic PGC-1β may ameliorate combined hyperlipidemia and improve the effects of PPAR{alpha} activators.  

Aleksandr E. Vendrov, Zeenat S. Hakim, Nageswara R. Madamanchi, Mauricio Rojas, Chaitanya Madamanchi, and Marschall S. Runge
Arterioscler Thromb Vasc Biol. 2007;27:2714-2721; published online before print September 6 2007, doi:10.1161/ATVBAHA.107.152629
Abstract | Full Text | PDF | Data Supplement
We investigated the relative contribution of monocyte/macrophage versus vascular wall cell NAD(P)H oxidase to atherosclerosis using bone marrow transplantation from apoE-/-/p47phox-/- mice to apoE-/- mice and vice versa. Monocytes/macrophages and vascular wall NAD(P)H oixdases contribute equally to aortic superoxide production and atherosclerosis in apoE-/- mice.  

Anita M. Tuomainen, Kristiina Nyyssönen, Jari A. Laukkanen, Taina Tervahartiala, Tomi-Pekka Tuomainen, Jukka T. Salonen, Timo Sorsa, and Pirkko J. Pussinen
Arterioscler Thromb Vasc Biol. 2007;27:2722-2728; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.154831
Abstract | Full Text | PDF
We evaluated the predictive value of serum MMP-8 (MMP-8) concentration for cardiovascular disease (CVD) events in a prospective sample of men without cardiovascular events. The results show a 3.0-fold increase in risk for CVD death in men with both elevated MMP-8 level and subclinical atherosclerosis.  

Abigail Fraser, Ross Harris, Naveed Sattar, Shah Ebrahim, George Davey Smith, and D.A. Lawlor
Arterioscler Thromb Vasc Biol. 2007;27:2729-2735; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.152298
Abstract | Full Text | PDF | Data Supplement
In a meta-analysis of prospective population based studies, GGT was associated with vascular events even among nondrinkers. ALT was also associated with these outcomes. Therefore it is possible that GGT reflects other biological processes such as oxidative stress or liver steatosis, or lifestyle behaviors that are linked to cardiovascular disease.  

Alexander P. Reiner, Christopher S. Carlson, Nancy S. Jenny, J. Peter Durda, David S. Siscovick, Deborah A. Nickerson, and Russell P. Tracy
Arterioscler Thromb Vasc Biol. 2007;27:2736-2742; published online before print September 20 2007, doi:10.1161/ATVBAHA.107.154559
Abstract | Full Text | PDF | Data Supplement
A common haplotype of the gene encoding upstream transcription factor 1 previously associated with decreased susceptibility to familial combined hyperlipidemia is associated with lower cholesterol levels and decreased atherosclerotic risk in young adults, but with increased inflammatory markers and increased mortality in older adults.  

Simon R. Thompson, Daniela Novick, Carmel J. Stock, Julie Sanders, David Brull, Jackie Cooper, Patricia Woo, George Miller, Menachem Rubinstein, and Steve E. Humphries
Arterioscler Thromb Vasc Biol. 2007;27:2743-2749; published online before print October 19 2007, doi:10.1161/ATVBAHA.107.149245
Abstract | Full Text | PDF | Data Supplement
The affect of elevated IL-18 levels and the implications of variation within the IL-18 system genes was investigated. In both healthy and diseased individuals, IL-18, determined in part by common variation within IL18, was predictive of adverse outcomes, suggesting IL-18 may play a role in CHD development and postsurgery outcome.  

Alberto Radaelli, Claudia Loardi, Maria Cazzaniga, Giulia Balestri, Caterina DeCarlini, M. Grazia Cerrito, Elena Negro Cusa, Luca Guerra, Stefano Garducci, Danilo Santo, Lorenzo Menicanti, Giovanni Paolini, Arianna Azzellino, Maria Luisa Lavitrano, Giuseppe Mancia, and Alberto U. Ferrari
Arterioscler Thromb Vasc Biol. 2007;27:2750-2755; published online before print September 6 2007, doi:10.1161/ATVBAHA.107.149039
Abstract | Full Text | PDF
CABG surgery triggers inflammation. Modulation of this response by statins/ACE-inhibitors (ACEI) was tested. Patients undergoing CABG were randomized to statin/ACEI treatment at standard (STD) or high doses (HiDo). Inflammatory mediators were assayed. Striking increases in inflammatory mediators were observed in the STD but not the HiDo group. CABG-related inflammatory response can be prevented by high doses of ACEI/statins.  

Gábor Széplaki, Lilian Varga, Judit Laki, Edit Dósa, Szabolcs Rugonfalvi-Kiss, Hans O. Madsen, Zoltán Prohászka, Andrea Kocsis, Péter Gál, Attila Szabó, György Acsády, István Karádi, László Selmeci, Peter Garred, George Füst, and László Entz
Arterioscler Thromb Vasc Biol. 2007;27:2756-2762; published online before print October 4 2007, doi:10.1161/ATVBAHA.107.146860
Abstract | Full Text | PDF | Data Supplement
Concentrations of C1-inhibitor were determined in samples serially taken from patients who were followed-up after carotid endarterectomy. Low C1-INH levels at 6-weeks postsurgery predicted the development of an early restenosis, indicating that it might be a marker in the identification of patients with high risk for early restenosis.  

Domenico Ferro, Lorenzo Loffredo, Licia Polimeni, Filippo Fimognari, Paolo Villari, Pasquale Pignatelli, Valentin Fuster, and Francesco Violi
Arterioscler Thromb Vasc Biol. 2007;27:2763-2768; published online before print September 27 2007, doi:10.1161/ATVBAHA.107.152777
Abstract | Full Text | PDF
This prospective study provides evidence that enhanced plasma levels of sCD40L (>4.76 ng/mL) are predictive of cardiovascular events in patients with nonvalvular atrial fibrillation, thus suggesting that enhanced platelet activation may play a pivotal role in its clinical progression.  

 

ThrombosisBack

Barbara E. Stähli, Alexander Breitenstein, Alexander Akhmedov, Giovanni G. Camici, Kushiar Shojaati, Nikolay Bogdanov, Jan Steffel, Daniel Ringli, Thomas F. Lüscher, and Felix C. Tanner
Arterioscler Thromb Vasc Biol. 2007;27:2769-2776, doi:10.1161/ATVBAHA.107.153502
Abstract | Full Text | PDF
Inhibition of Na+/K+-ATPase by ouabain inhibited TNF-{alpha}-induced endothelial TF protein expression via a reduced protein translation. TF mRNA expression was not inhibited, and TF protein stability remained unaffected. This observation provides novel insights into posttranscriptional regulation of TF expression in culture.  

Ruby L.C. Hoo, W.S. Chow, M.H. Yau, A. Xu, Annette W.K. Tso, H.F. Tse, Carol H.Y. Fong, Sidney Tam, Lawrence Chan, and Karen S.L. Lam
Arterioscler Thromb Vasc Biol. 2007;27:2777-2782; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.152462
Abstract | Full Text | PDF | Data Supplement
We demonstrated that rosiglitazone-mediated elevation of plasma adiponectin level is independently associated with the reduction in PAI-1 concentrations in diabetic patients. The suppressive effect of rosiglitazone on PAI-1 production was attenuated in adiponectin-deficent mice, whereas over-expression of adiponectin decreased PAI-1 production. Recombinant adiponectin inhibited PAI-1 expression in 3T3-L1 adipocyte.  

Angela M. Carter, Charlotte M. Cymbalista, Tim D. Spector, Peter J. Grant on behalf of the EuroCLOT Investigators
Arterioscler Thromb Vasc Biol. 2007;27:2783-2789; published online before print October 11 2007, doi:10.1161/ATVBAHA.107.153221
Abstract | Full Text | PDF | Data Supplement
Heritabilities of turbidimetric measures of structure/function were {approx}0.30 in the Leeds Family Study. Clot structure/function was related to presence of the metabolic syndrome and number of metabolic syndrome components. Identification of the genetic and environmental factors influencing clot structure/function may further our understanding of factors predisposing to cardiovascular disease.  

 

Author IndexBack

Author Index


Arterioscler Thromb Vasc Biol. 2007;27:2790-2798, doi:10.1161/ATVBAHA.107.188280
PDF  

 

Letters to the EditorBack

A Comparison of Lupus Anticoagulant–Positive Patients With Clinical Picture of Antiphospholipid Syndrome and Those Without

Vittorio Pengo, Alessandra Biasiolo, Paolo Gresele, Francesco Marongiu, Nicoletta Erba, Fabio Veschi, Angelo Ghirarduzzi, Doris Barcellona, and Armando Tripodi
Arterioscler Thromb Vasc Biol. 2007;27:e309-e310; published online before print December 1 2007, doi:10.1161/ATVBAHA.107.153536
Extract | Full Text | PDF  

A Highly Efficient Method to Differentiate Smooth Muscle Cells From Human Embryonic Stem Cells

Chang-Qing Xie, Jifeng Zhang, Luis Villacorta, Taixing Cui, Huarong Huang, and Y. Eugene Chen
Arterioscler Thromb Vasc Biol. 2007;27:e311-e312; published online before print December 1 2007, doi:10.1161/ATVBAHA.107.154260
Extract | Full Text | PDF | Data Supplement  

Spotlight

TOC Spotlight File Banner1TOCpage

Banner2TOCpage